Celularity
CELU
61 hedge funds and large institutions have $21.3M invested in Celularity in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 19 closing their positions.
6,633% more call options, than puts
Call options by funds: $202K | Put options by funds: $3K
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more ownership
Funds ownership: 2.36% → 2.37% (+0%)
16% less funds holding
Funds holding: 73 → 61 (-12)
52% less capital invested
Capital invested by funds: $44.3M → $21.3M (-$23M)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFO
Biltmore Family Office
Charlotte,
North Carolina
|
+$202K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$173K |
| 3 |
Renaissance Technologies
New York
|
+$45.4K |
| 4 |
GCM
Gladius Capital Management
Chicago,
Illinois
|
+$33.7K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$33.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$190K |
| 2 |
Swiss National Bank
Zurich,
Switzerland
|
-$155K |
| 3 |
D.E. Shaw & Co
New York
|
-$98.1K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$73K |
| 5 |
Jane Street
New York
|
-$42.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PMEF
76
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | -$7.74K | -600 | Closed |
|
77
Simplex Trading
Chicago,
Illinois
| – | -$1.79K | -222 | -69% |
|
78
Citigroup
New York
| – | -$2.62K | -203 | Closed |
|
79
Osaic Holdings
Scottsdale,
Arizona
| – | -$1K | -100 | Closed |
|
|
CG
80
Cutler Group
San Francisco,
California
| – | -$161 | -20 | Closed |
|
CELU Hedge Fund Activity: Q1 2023 in Review
61 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2023, worth a combined $21.3M — down 52% from $44.3M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CELU and 7 opened new positions — a net loss of 12 holders — while 16 trimmed existing stakes and 19 added.
The largest buyer was Biltmore Family Office, adding an estimated $202K. The largest seller was BlackRock, cutting an estimated $190K.
- 61 institutional investors held Celularity (CELU) as of Q1 2023, down from 73 in Q4 2022.
- Funds reported $21.3M of Celularity stock for Q1 2023, down 52% quarter-over-quarter.
- 7 funds opened new Celularity positions in Q1 2023 and 19 closed out, a net change of -12 holders.
- The largest Celularity buyer in Q1 2023 was Biltmore Family Office, an estimated $202K added.
- The largest Celularity seller in Q1 2023 was BlackRock, an estimated $190K sold.
Based on aggregated 13F filings for Q1 2023.